Abstract
It has been well-documented that administration of opioids can alter immune function in vitro. Initial studies of chronic heroin users demonstrated that this population has decreased mitogenic responsiveness of blood lymphocytes to lipopolysaccharide, poke- weed mitogen, and concanavalin-A, suggesting an impairment of cellular immunity (1). Subsequent studies have shown that chronic heroin users also exhibit diminished T-cell E-rosetting (2), reductions in the total number of T-cells present in the peripheral blood (3), and decreases in the number of T-helper cells in the blood (4). Taken together, these studies demonstrate that chronic heroin use can alter immune function, and may thereby affect disease susceptibility and pathogenesis.
The research described in this article has been reviewed by the Health Effects Research Laboratory, U.S. Environmental Protection Agency, and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the agency, nor does mention of trade names or commercial products constitute endorsement or recommendation of use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown, B. Stimmell, R.N. Taub, S. Kochwa, and R.E. Rosenfield, R.E., Immunologic dysfunction in heroin addicts, Arch. Int. Med, 134: 1001 (1974).
R.M. Donahoe, J.J. Madden, F. Hollingworth, D. Shafer, and A. Falek, Morphine depression of T-cell E-rossetting: Definition of the process, Proc. Am. Soc. Exp. Biol., 44: 95 (1985).
R.J. McDonough, J.J. Madden, A. Falek, D.A. Shafer, M. Pline, D. Gordon., P. Bokos, J.C. Kuehnie, and J. Mendelson, Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: In vivo evidence for opiate receptor sites on T lymphocytes, J. Immunol., 125: 2539 (1980).
R.M. Donahoe, C. Buesos-Ramos, F. Donahoe, J.J. Madden, and A. Falek, Mechanistic implications of the finding that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers, Ann. New York Acad. Sci., 496: 711 (1987).
H.U. Bryant, E.W. Bernton, and J.W. Holaday, Immunosuppressive effects of chronic morphine treatment in mice, Life Sci., 41: 1731 (1987).
H.U. Bryant, E.W. Berton, E.W., and J.W. Holaday, Morphine pellet-induced immunomodulation in mice: Temporal relationships, J. Pharm. Exp. Ther., 245: 913 (1988).
R.J. Weber, B. Ikejiri, K.C. Rice, A. Pert, and A.A. Hagan, Opiate receptor mediated regulation of the immune response in vivo, in Problems of Drug Dependence, L.S. Harris. Ed., NIDA Res. Monogr., 76: 341 (1987).
Y. Shavit, J.W. Lewis, G.W. Terman, R.P. Gale, and J.C. Liebeskind, Opioid peptides mediate the suppres-sive effect of stress on natural-killer cell cytotoxicity, Science, 223: 188 (1984).
S.S. Lefkowitz and C.Y. Chiang, Effects of certain abused drugs on hemolysin forming cells, Life Sci., 17: 1763 (1975).
E. Tubaro, G. Borelli, C. Croce, G. Cavallo, and C. Santiangeli, Effect of morphine on resistance to infection, J. Infect. Dis., 148: 656 (1983).
D.T. Lysle, M.E. Coussons, V.J. Watts, E.H. Bennett, and L.A. Dykstra, Morphine-induced alterations of immune status: Dose-dependency, compartment specificity, and antagonism by naltrexone, J. Pharm. Exp. Ther., 265: 1071 (1993).
B.M. Bayer, S. Daussin, M. Hernandez, and L. Irvin, Morphine inhibition of lymphocyte activity is mediated by and opioid-dependent mechanism, Neuropharm., 29: 369 (1990).
J.P. Ehrlich and G.R. Burleson, Enhanced and prolonged pulmonary influenza virus infection following phosgene inhalation, J. Toxicol. and Environ. Health, 34: 259 (1991).
K. Gylires, I. Budavari, S. Fürst, and I. Molnar. Morphine inhibits the carrageenan-induced oedema and the chemoluminescence of leucocytes stimulated by zymosan, J. Pharm. Pharmacol., 37: 100 (1985).
P. Sacerdote, M. Bianchi, and A.E. Panerai, Involvement of B-endorphin in the modulation of paw inflammatory edema in the rat, Reg. Peptides, 63: 79 (1996).
D. H. Broide, Inflammatory Cells: Structure and Function, in Basic and Clinical Immunology, D.P., Stiles and A.I. Terr Eds., Appleton and Lange, Norwalk (1991).
R.J. Weber and A. Pert, The periaqueductal grey matter mediates opiate-induced immunosuppression, Science, 245: 188 (1989).
P.J. Cabot, T. Crammond, and M.T. Smith, Quantitative autoradiography of peripheral opioid binding sites in rat lung, Euro. J. Pharm., 310: 47 (1996).
P.J. Cabot, P.R. Dodd, T. Crammond, and M.T. Smith, Characterization of non-conventional opioid binding sites in rat and human lung, Euro. J. Pharm., 268: 247 (1994).
H. Lebrec, K. Sarlo, and G.R. Burleson, Effect of influenza virus infection on ovalbumin-specific IgE responses to inhaled antigen in the rat, J. Toxicol. Environ. Health, 49: 619 (1996)
J.P. Ehrlich, A.F. Gunnison, and G. R. Burleson, Influenza virus-specific cytotoxic T-lymphocyte activity in Fischer 344 rat lungs as a method to assess pulmonary immunocompetence: Effect of phosgene inhalation, Inhal. Toxicol., 1: 129 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Coussons-Read, M.E., Daniels, M., Gilmour, M.I. (1998). Morphine Alters the Immune Response to Influenza Virus Infection in Lewis Rats. In: Friedman, H., Madden, J.J., Klein, T.W. (eds) Drugs of Abuse, Immunomodulation, and Aids. Advances in Experimental Medicine and Biology, vol 437. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5347-2_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5347-2_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7439-8
Online ISBN: 978-1-4615-5347-2
eBook Packages: Springer Book Archive